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  This study was performed to produce transgenic Korean 
native goat (Capra hircus) by laparoscopic embryo transfer 
(ET)  to  overcome  the  limitations  of  ET  performed  by 
laparotomy. Transgenic embryos were produced by DNA 
pronuclear microinjection of in vivo zygotes. The recipient 
goats were synchronized for estrus by using an introvaginal 
progesterone  devices  as  a  controlled  internal  drug- 
releasing insert (CIDR) for 13 days and injection of 400 IU 
PMSG 48 h before removal of the insert. Embryos were 
transferred on day  3 and 4 after removal  of the  insert. 
Recipient  goats  were  deprived  of  feed  for  48  h,  then 
suspended in a laparotomy cradle at an angle of 45
o. After 
obtaining a sufficient pneumoperitoneum, the laparoscope 
and  forceps  were  inserted  abdominally  through  5  mm 
trocar sleeves. Examination of the ovaries and uterus was 
performed and then 213 embryos were transferred into the 
oviducts  via  the  infundibula  of  76  recipient  goats.  To 
compare  pregnancy  rates,  ET  was  also  performed  by 
laparotomy in 82 recipient goats. The pregnancies in the 
recipient goats were diagnosed by ultrasound on day 30 
after  embryo  transfer.  The  pregnancy  rate  with 
laparoscopic  ET  was  significantly  higher  than  with  ET 
performed by laparotomy (46.1% vs. 28.6%, p ＜ 0.05). In 
addition,  the  pregnancy  rates  were  compared  between 
ovulated and non-ovulated ovaries of the recipient goats in 
the laparoscopic ET group. No significant difference was 
observed  between  the  pregnancy  rates  of  ovulated  and 
non-ovulated ovaries (41.3% vs. 33.3%, p ＜ 0.05) suggesting 
that ET may also be possible in non-ovulated recipients 
through  artificial  rupture  of  Graafian  follicles.    These 
results suggest that laparoscopic ET is a highly efficient 
method for the transfer of goat embryos. 
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Introduction 
  The mammary gland of transgenic farm animals has been 
proposed as the best available bioreactor for the production 
of human pharmaceutical proteins [4,5,13,21]. Dairy goats 
have been used as a bioreactor because of their relatively 
short gestation period and low maintenance costs compared 
to cattle. Many studies have reported on the production of 
transgenic goats [6-8,11]. The possibility of large-scale 
production for industrial application has been demon-
strated [9,10]. In Korea, transgenic goats have been used to 
produce human granulocyte colony stimulating factor 
(G-CSF) in their milk [15,18].
  To date, laparotomy methods have generally been used 
for goat embryo transfer (ET). However, this method can 
cause adhesions in the reproductive tract following 
repeated surgical ET and requires relatively long intervals 
before the re-use of a recipient female [15,18]. To overcome 
the limitations of laparotomy, laparoscopic ET has been 
performed in various species including sheep [19,20], 
cows [12] and pigs [3]. The laparoscopic method has also 
been performed in goats [1,2,16,17,24]. However, in the 
above mentioned studies, the laparoscopic method was 
used only for oocyte recovery by ovum pick-up and embryo 
recovery but not for embryo transfer. 
  Estrus synchronization is essential for successful ET and 
corpus luteum (CL) formation is necessary for pregnancy 
maintenance. However, it is difficult to know the exact 
status of the ovaries if they are not observed directly by 
exploratory surgery or ultrasonography. Therefore, if the 
CL is not formed during ET, artificial formation of the CL 
by follicle puncture is necessary for ovulation and 
progesterone support is required to maintain the pregnancy 
or the ET must be postponed until CL formation. 
  In the present study, we performed laparoscopic ET to 
overcome the limitations of laparotomy in the production 
of transgenic goats. The pregnancy rates resulting from the 
two methods were compared in the Korean native goat 104    Sang Tae Shin et al.
Table 1. The superovulation and estrous synchronization 
schedule for the donor and recipient Korean native goats
Donor goats Recipient goats
Day AM PM PM
-14
-3
-2
-1
 0
 1
 3
PMSG 150 iu IM
FSH 0.9 mg IM
FSH 0.9 mg IM
FSH 0.9 mg IM
FSH 0.9 mg IM
Embryo recovery
CIDR insert*
FSH 0.9 mg IM
FSH 0.9 mg IM
FSH 0.9 mg IM
CIDR remove
FSH 0.9 mg IM
hCG 200 iu IM
Mating (overnight)
CIDR insert
PMSG 400 iu IM
CIDR remove
hCG 200 iu IM
Embryo transfer
*Intravaginal progesterone insertion with controlled internal drug- 
releasing insert (CIDR). 
(Capra hircus). In addition, the pregnancy rates were 
compared between ovulated and non-ovulated animals in 
the laparoscopic ET group. 
Materials and Methods
Synchronization and embryo collection 
  In this study, Korean native goats with a body weight 
ranging from 15 to 25 kg were used as donors and 
recipients from September to April 2001-2002. All goats 
were fed alfalfa/grass hay and a commercial diet with free 
access to water and trace-minerals. The estrous periods of 
the donors were synchronized using an intravaginal 
progesterone devices such as a controlled internal drug- 
releasing insert (CIDR; Pharmacia & Upjohn, New 
Zealand) for 13 to 14 days irrespective of the natural 
estrous cycles (Table 1). Superovulation was induced 
following combined treatment with FSH (ICPbio, New 
Zealand), PMSG (Horizon Technology, Australia) and 
hCG (Sigma, USA). FSH (0.9 mg/goat) was administered 
to the goats over a 4-day period, at 12-h intervals, starting 
2.5 days before CIDR removal and continuing within 1 day 
of CIDR removal. PMSG (150 IU) was administrated at 
the time of the first FSH administration and hCG (200 IU) 
was administrated at the time of the last FSH injection to 
induce ovulation. The donors demonstrated estrus within 
24 h following the CIDR removal and were mated with 
fertile bucks. At 66 h after the CIDR removal, embryos 
were surgically recovered by flushing both oviducts. All 
donors were fasted 24 h prior to surgery. A low dose of 
xylazine hydrochloride (0.12 mg/kg BW; Bayer Korea, 
Korea) was injected (im) as a pre-anesthetic agent. After a 
subcutaneous injection of lidocaine (0.1 g/ animal, Kwang-
myung Pharm, Korea) for local anesthesia, a midventral 
incision was made and the reproductive tract exteriorized. 
The ovaries were examined for fresh ovulation sites to 
provide an estimate of the number of embryos. The oviducts 
were flushed with sterile phosphate-buffered saline. The 
recipient goats were also synchronized with the donor 
doses for 13 d using the CIDR with a single injection of 400 
IU PMSG two days before CIDR removal. As no FSH was 
administered to the recipient goats, the injection of hCG 
and removal of the CIDR were both performed one day 
before they were performed in the donor goats. 
Embryo manipulation and microinjection 
    Immediately after flushing, the number of oocytes/ 
embryos was evaluated for each donor under a stereo-
microscope. Zygotes were microcentrifuged at 10,000 g 
for 7 min to improve pronuclei visualization and the 
injection of DNA. A 3.7 kb BaaH II/Kpn I fragment of 
pGbc-hGCSF, in which the hG-CSF (human granulocyte- 
colony stimulating factor) gene was fused as the promoter 
sequence with the goat β-casein gene, was injected into one 
of the pronuclei of the 1-cell embryos. Following 
microinjection, the embryos were placed into modified 
synthetic oviduct fluid (mSOF) supplemented with 10% 
FBS and cultured for 1 or 2 h in a humidified (38.5
oC) 5% 
CO2 incubator until transfer [22]. 
Embryo transfer 
  The equipment used for laparoscopic surgery included 
the following: a 5-mm laparoscope (MGB, Germany), a 
charge coupled device (IK-C43H 47; Toshiba, Japan), a 
flexible fiber-optic cable (Olympus, Japan), a camera 
control unit (IK-Cu43A; Toshiba, Japan), a light source 
(CLV- E; Olympus, Japan), a 5-mm trocar (MGB, Germany), 
a 5-mm laparoscopic assistant forceps for dissection, 
atraumatic grasping and allis forceps (MGB, Germany), 
and a 5-mm injection needle (MGB, Germany). Embryo 
transfer was performed 4 days after removal of the CIDR. 
The recipient goats were starved for 48 h prior to ET, and 
xylazine hydrochloride (0.7 mg/kg, IM) was administered 
as an anesthetic agent. The anesthetized goats were 
suspended head down on a laparotomy table at an angle of 
45
o. After disinfection of the surgical area, 2% lidocaine 
was infused for local anesthesia at the site of the proposed 
puncture. A Verres needle (Vomed, Germany) was inserted 
through the abdominal wall to create a pneumoperitoneum 
using a CO2 automatic insufflator. After obtaining a 
sufficient pneumoperitoneum, a 5-mm middle incision 
was made in the skin cranial to the mammary gland. The 
trocar was passed through the abdominal wall, the trocar 
sleeve was inserted and the laparoscope was inserted 
through the trocar sleeve. An injection needle was inserted 
cranial to the laparoscope and forceps were inserted lateral Laparoscopy vs. laparotomy for embryo transfer    105
Fig. 1. Injection set for laparoscopic embryo transfer and embryo
loading. (A) 5-cm polyethylene tube (1), injection needle (2) and
1-ml syringe (3). (B) Embryo loading in the injection needle.
Fig. 2. Laparoscopic embryo transfer. (A) Infundibulum was 
grasped with assist forceps, and then inserted into a polyethylene
tube. (B) Insertion of polyethylene tube into the ampulla via the 
infundibulum. (C) Swollen oviduct after embryo transfer. (D) 
Preventing back flow of medium into the abdominal cavity by 
grasping the infundibulum with assist forceps.
Table 2. Comparison of pregnancy rates between laparoscopic 
and laparotomic embryo transfer
Method of 
embryo transfer
Transferred 
embryos
† Recipients
† Pregnancies
† 
(%)
Laparoscopic
Laparotomic
213
232
76
82
35 (46.1)
a
22 (26.8)
b
a,bValues in the same column with different superscripts are different
(p ＜ 0.05). 
†: number.
to the injection needle. After examination of the ovaries, 
oviducts and uterine horns, the embryos were transferred. 
  The stage and quality of the embryos were evaluated 
under a stereomicroscope, and the embryos were loaded 
into a polyethylene tube (SP65; Nastume, Japan) attached 
to the injection needle (Fig. 1). With the forceps, the 
infundibulum was grasped (Fig. 2A), the polyethylene 
tube was inserted into the oviduct via the infundibulum 
(Fig. 2B), and 2 to 3 embryos were then transferred (Fig. 
2C). After transferring the embryos, the back flow of the 
medium, into the abdominal cavity, was prevented by 
grasping the infundibulum with the forceps (Fig. 2D). The 
polyethylene tube was washed with medium, then checked 
for any remaining embryos. Recipient goats were used up 
to three to four times if no pregnancy was established after 
the ET. 
  To compare the pregnancy rates, ET by laparotomy was 
performed as described previously [18]. Briefly, 2-3 
embryos were surgically transferred into 1 oviduct ipsilateral 
to the ovulated ovary, using a syringe connected to a sterile 
polyethylene tube, which was inserted into the oviduct 
lumen via the fimbria. The pregnancies were diagnosed by 
transrectal ultrasound scanning (SonoVet 600; Medison, 
Korea) using a transrectal 5-MHz linear array probe on day 
30 and 40 following ET in both groups.
Experimental design 
    The pregnancy rates following ET were compared 
between the laparoscopy and laparotomy groups in 
experiment 1. In experiment 2, the recipient goats were 
classified into two groups based on whether they had 
ovulated or non-ovulated ovaries (GF; ovary with Graafian 
follicle that was non-ovulated, CH; ovary with corpus 
hemorrhagicum after ovulation). The pregnancy rates were 
compared after the laparoscopic ET. In the GF group, the 
non-ovulated follicle was ruptured artificially by needle 
puncture prior to the ET. This experiment was performed to 
investigate the effects of artificial rupture, of non-ovulated 
Graafian follicles, on the efficiency of laparoscopic ET. 
Statistical analysis 
  All values for each parameter were analyzed by ANOVA 
using a general linear model (PROC-GLM) in the SAS 8.1 
program (p ＜ 0.05). 
Results
  A comparison of the pregnancy rates between the 
laparoscopic ET and ET by laparotomy revealed that there 
was a significant difference between the two methods of 
ET (Table 2). Following the laparoscopic method, 213 
transgenic embryos were transferred to 76 recipient goats 
and 35 recipients (46.1%) became pregnant. However, 
with the ET by laparotomy, only 22 out of the 82 recipients 106    Sang Tae Shin et al.
Table 3. Comparison of pregnancy rates according to ovarian 
findings of the recipient goat with laparoscopic embryo transfer
Ovarian 
cycle
Transferred 
embryos
† Recipients
† Pregnancies
†
(%)
Graafian follicle
Corpus hemorrhagicum
  25
131
  9
46
  3 (33.3)
19 (41.3)
†: number.
(26.8%) became pregnant. No significant difference was 
observed in the pregnancy rates between the ovulated (CH) 
and non-ovulated (GF) groups (Table 3). 
Discussion
  The results of this study showed a significantly higher 
pregnancy rate with laparoscopic ET compared to ET by 
laparotomy. Tittel et al. [23] noted that laparoscopic 
adhesiolysis resulted in a significantly reduced number of 
new adhesions compared to open surgery. The operation 
was performed only in transferable recipients after 
laparoscopic exploration of the ovary and uterus. 
    For efficient production of transgenic goats, by pro-
nuclear microinjection, the pregnancy rate following ET is 
important. Relatively higher pregnancy rates have been 
recorded when transferring non-transgenic embryos by 
laparotomy ET [14], compared to the pregnancy rates after 
the transfer of transgenic embryos [18]. In previous studies 
using Korean native goats as recipients, the pregnancy rate 
following laparoscopic ET was lower than the rate 
observed in our study (25.7% and 36.8% vs. 46.1%). 
  The findings of our study suggest that by decreasing the 
disadvantages of ET by laparotomy, we achieved better 
results with laparoscopic ET. However, our pregnancy rate 
with ET by laparotomy was lower than reported in a 
previous study [11], suggesting that additional studies 
might lead to an improvement in pregnancy rates of ET by 
laparotomy. 
  We also compared the pregnancy rates between the GF 
and CH groups to evaluate the effects of artificial rupture 
on the non-ovulated Graafian follicles. When Graafian 
follicles were identified by laparoscopic ET, they were 
ruptured artificially for formation of the CL, essential for 
the maintenance of a pregnancy. We then investigated the 
effects of the artificially ruptured Graafian follicles by 
comparison of the pregnancy rates. The most appropriate 
period for transferring an embryo is within 24 h after 
ovulation.  Although the recipient goats were synchronized 
with progesterone and PMSG for the ET, some of the 
recipient goats had not ovulated at the time of the ET. Out 
of 55 recipient goats, nine goats (16.4%) had not yet 
ovulated with the Graafian follicle and 46 goats (83.6%) 
were estimated to have passed beyond the 24 h after 
ovulation by observation of the corpus luteum (CL). In 
comparison of the pregnancy rates, there was no significant 
difference between the CH and GF groups (41.3% vs. 
33.3%, respectively, p ＞ 0.05). Although the pregnancy 
rates were lower than in the CH group, an acceptable 
pregnancy rate was achieved by artificial rupture in the GF 
group. Therefore, in cases with a non-ovulated Graafian 
follicle, artificial rupture was efficient for the formation of 
the CL, essential for pregnancy maintenance after embryo 
transfer. However, if artificial rupture was not performed in 
the Graafian follicle, medical induction of ovulation or 
additional embryo transfer after CL formation was needed. 
  The results of this study demonstrated that laparoscopic 
ET was a reliable and effective technique for efficient 
production of transgenic goats after pronuclear DNA 
microinjection. In addition, we found that artificial rupture 
of the Graafian follicle was an efficient method for the 
formation of the CL for pregnancy maintenance. More 
work is needed to better understand the factors involved in 
this process for further improvement of the pregnancy rate 
in caprine laparoscopic ET.  
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